{"id":10212,"date":"2026-07-15T09:35:53","date_gmt":"2026-07-15T07:35:53","guid":{"rendered":"https:\/\/cleanpeptides.eu\/tb-500-doseringsguide\/"},"modified":"2026-07-15T09:35:53","modified_gmt":"2026-07-15T07:35:53","slug":"tb-500-doseringsguide","status":"publish","type":"page","link":"https:\/\/cleanpeptides.eu\/da\/tb-500-doseringsguide\/","title":{"rendered":"TB-500 doseringsguide: opladning, vedligeholdelse og kure"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><em>Thymosin beta-4-fragment \u2014 oplednings-, vedligeholdelses- og cyklusprotokoller, rekonstituering, kombination med BPC-157 og sikkerhed. Kun til forskningsform\u00e5l \u2014 ikke til human brug.<\/em><\/p>\n<p class=\"wp-block-paragraph\">Clean Peptides giver ikke r\u00e5dgivning om dosering eller anvendelse. Denne guide samler produktinformation fra Clean Peptides sammen med uafh\u00e6ngigt undervisningsmateriale fra PeptideWiki, kun som forskningsreference. Det er ikke medicinsk r\u00e5dgivning og udg\u00f8r hverken anbefalinger, godkendelser eller instruktioner fra Clean Peptides.<\/p>\n<h2 class=\"wp-block-heading\">Hvad er TB-500?<\/h2>\n<p class=\"wp-block-paragraph\">TB-500 er et syntetisk peptidfragment af thymosin beta-4 (T\u03b24), et naturligt forekommende protein p\u00e5 43 aminosyrer, der findes i n\u00e6sten alle celler. Det svarer til aktinbindingsdom\u00e6net (aminosyre 17\u201323), der er ansvarligt for v\u00e6vsreparation og antiinflammatoriske egenskaber. Ved at opregulere aktin fremmer det cellemigration, angiogenese og s\u00e5rheling. Effekten er systemisk \u2014 en enkelt injektion i maven kan underst\u00f8tte heling hvor som helst i kroppen.<\/p>\n<p class=\"wp-block-paragraph\">Doseringen stammer fra publiceret forskning og protokoller fra f\u00e6llesskabet.<\/p>\n<h2 class=\"wp-block-heading\">N\u00f8gleegenskaber<\/h2>\n<ul class=\"wp-block-list\">\n<li>Thymosin beta-4-fragment \u2014 aktiv region (aa 17\u201323) af det 43-aa store T\u03b24-protein.<\/li>\n<li>Aktinopregulering \u2014 fremmer cellemigration, -proliferation og -differentiering.<\/li>\n<li>Systemisk fordeling \u2014 effekt i hele kroppen fra \u00e9t injektionssted.<\/li>\n<li>Antiinflammatorisk \u2014 nedregulerer proinflammatoriske cytokiner.<\/li>\n<li>Angiogenese \u2014 fremmer dannelsen af nye blodkar.<\/li>\n<li>Forskningspeptid \u2014 ikke FDA-godkendt; forbudt af WADA.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">S\u00e5dan fastl\u00e6gges doseringen<\/h2>\n<p class=\"wp-block-paragraph\">Protokollerne stammer fra dyrefors\u00f8g om s\u00e5rheling, veterin\u00e6r brug hos heste og erfaring fra f\u00e6llesskabet. Tofaset opladnings-\/vedligeholdelsestilgang stammer fra veterin\u00e6re anvendelser. F\u00e6llesskabsstandarden konvergerede ved 2\u20132,5 mg pr. injektion. Evidensstyrke: moderat\u2013lav for human brug.<\/p>\n<h2 class=\"wp-block-heading\">Standarddoseringsintervaller<\/h2>\n<h3 class=\"wp-block-heading\">Opladningsfase<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Protokol<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dosis\/injektion<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Ugentligt total<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Varighed<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Konservativ<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20136 uger<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Standard<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20136 uger<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Aggressiv<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">7,5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4 uger<\/td>\n<\/tr>\n<\/table>\n<h3 class=\"wp-block-heading\">Vedligeholdelsesfase<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Protokol<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dosis\/injektion<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Varighed<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Standardvedligeholdelse<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20138 uger<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Lavfrekvent vedligeholdelse<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Hver 2. uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20138 uger<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Forl\u00e6nget vedligeholdelse<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6\u20138 uger<\/td>\n<\/tr>\n<\/table>\n<h3 class=\"wp-block-heading\">V\u00e6gtbaseret reference<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Kropsv\u00e6gt<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Opladning<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Vedligeholdelse<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Under 68 kg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg 2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg 1\u00d7\/uge<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">68\u201390 kg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg 2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg 1\u00d7\/uge<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Over 90 kg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg 2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg 1\u00d7\/uge<\/td>\n<\/tr>\n<\/table>\n<h2 class=\"wp-block-heading\">Rekonstituering og dosering (med de medf\u00f8lgende 3 mL)<\/h2>\n<p class=\"wp-block-paragraph\">Hvert Clean Peptides-h\u00e6tteglas leveres med 3 mL bakteriostatisk vand (0,9 % benzylalkohol). Alle tal nedenfor foruds\u00e6tter rekonstituering med de fulde 3 mL. P\u00e5 en standard U-100-insulinspr\u00f8jte er 100 enheder = 1 mL. Hurtig formel: koncentration = h\u00e6tteglasstyrke \u00f7 3 mL, og enheder at tr\u00e6kke op = dosis (mg) \u00d7 300 \u00f7 h\u00e6tteglasstyrke (mg).<\/p>\n<h3 class=\"wp-block-heading\">S\u00e5dan rekonstitueres<\/h3>\n<ol class=\"wp-block-list\">\n<li>Vask h\u00e6nderne og l\u00e6g h\u00e6tteglasset, de 3 mL bakteriostatisk vand, en insulinspr\u00f8jte og spritservietter frem p\u00e5 en ren overflade.<\/li>\n<li>Vip h\u00e6tterne af og aft\u00f8r begge gummipropper med sprit; lad dem luftt\u00f8rre 10\u201315 sekunder.<\/li>\n<li>Tr\u00e6k de fulde 3 mL bakteriostatisk vand op (i tre 1 mL-omgange med en insulinspr\u00f8jte eller i \u00e9n omgang med en 3 mL-spr\u00f8jte).<\/li>\n<li>Tils\u00e6t vandet langsomt, og vinkl n\u00e5len, s\u00e5 det l\u00f8ber ned ad den indvendige glasv\u00e6g \u2014 spr\u00f8jt det aldrig direkte p\u00e5 pulveret.<\/li>\n<li>Opl\u00f8s forsigtigt \u2014 lad h\u00e6tteglasset st\u00e5 1\u20132 minutter, og hvirvl eller rul det derefter mellem h\u00e5ndfladerne, til opl\u00f8sningen er klar. Ryst aldrig.<\/li>\n<li>M\u00e6rk og opbevar i k\u00f8leskab ved 2\u20138 \u00b0C. Resulterende koncentration: 5 mg \u2192 1,67 mg\/mL; 10 mg \u2192 3,33 mg\/mL.<\/li>\n<\/ol>\n<p class=\"wp-block-paragraph\"><strong>Opbevaring:<\/strong> ikke-rekonstitueret pulver i k\u00f8leskab (2\u20138 \u00b0C); rekonstitueret opl\u00f8sning i k\u00f8leskab og anvendt inden for 28\u201330 dage; m\u00e5 ikke fryses; beskyt mod lys og varme.<\/p>\n<h3 class=\"wp-block-heading\">Optr\u00e6ksvolumener med 3 mL \u2014 TB-500<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">H\u00e6tteglas (Clean Peptides)<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Koncentration<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">2 mg<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">2,5 mg<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,67 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">120 e*<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">150 e*<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">10 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3,33 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">60 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">75 e<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">* Overstiger kapaciteten p\u00e5 100 enheder (1 mL) i en standard insulinspr\u00f8jte \u2014 del op i to injektioner, eller brug en 3 mL-spr\u00f8jte. Tip: 10 mg-h\u00e6tteglasset holder injektionsvolumenerne lave.<\/p>\n<h2 class=\"wp-block-heading\">Dosering efter m\u00e5l<\/h2>\n<ul class=\"wp-block-list\">\n<li><strong>Sene- og ledb\u00e5ndsskader:<\/strong> opladning 2,5 mg 2\u00d7\/uge \u00d7 6 uger; vedligeholdelse 2 mg 1\u00d7\/uge \u00d7 6\u20138 uger. Ofte kombineret med BPC-157.<\/li>\n<li><strong>Muskelforstr\u00e6kninger og -rifter:<\/strong> opladning 2\u20132,5 mg 2\u00d7\/uge \u00d7 4 uger; vedligeholdelse 2 mg 1\u00d7\/uge \u00d7 4 uger.<\/li>\n<li><strong>Ledsmerter og bet\u00e6ndelse:<\/strong> opladning 2 mg 2\u00d7\/uge \u00d7 4\u20136 uger; vedligeholdelse 2 mg 1\u00d7\/uge eller hver 2. uge \u00d7 6\u20138 uger.<\/li>\n<li><strong>Postoperativ restitution:<\/strong> opladning 2,5 mg 2\u00d7\/uge \u00d7 4\u20136 uger (start 2\u20134 uger efter operationen); vedligeholdelse 2 mg 1\u00d7\/uge \u00d7 6\u20138 uger. Dr\u00f8ft timingen med din kirurg.<\/li>\n<li><strong>H\u00e5rv\u00e6kst:<\/strong> opladning 2 mg 2\u00d7\/uge \u00d7 4 uger; vedligeholdelse 2 mg 1\u00d7\/uge \u00d7 3\u20136 m\u00e5neder.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Injektionsguide<\/h2>\n<ol class=\"wp-block-list\">\n<li>Vask h\u00e6nderne grundigt.<\/li>\n<li>Aft\u00f8r proppen; tr\u00e6k dosis op i en 1 mL-insulinspr\u00f8jte; fjern luftbobler.<\/li>\n<li>V\u00e6lg og rens stedet \u2014 mave (5 cm fra navlen), yderl\u00e5r eller bagsiden af overarmen.<\/li>\n<li>Injicer SC i en l\u00f8ftet hudfold i 45\u00b0.<\/li>\n<li>Bortskaf i en kanyleb\u00f8tte.<\/li>\n<\/ol>\n<p class=\"wp-block-paragraph\">TB-500 (MW ~4963 Da) fordeler sig systemisk \u2014 ingen grund til at injicere n\u00e6r skaden. Skift mellem 3\u20134 steder. Adskil opladningsinjektioner med 3\u20134 dage.<\/p>\n<h2 class=\"wp-block-heading\">Kurvarighed og timing<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Protokol<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Opladning<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Vedligeholdelse<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Total<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Pause<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Kort (akut skade)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4 uger, 2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4 uger, 1\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">8 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20136 ugers pause<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Standard<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20136 uger, 2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6\u20138 uger, 1\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">10\u201314 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20138 ugers pause<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Forl\u00e6nget (kronisk skade)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6 uger, 2\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">8 uger, 1\u00d7\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6\u20138 ugers pause<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">Undg\u00e5 kontinuerlig brug ud over 14\u201316 uger uden pause; hold mindst 4 ugers pause mellem kure.<\/p>\n<h2 class=\"wp-block-heading\">Kombinationsprotokoller<\/h2>\n<p class=\"wp-block-paragraph\"><strong>TB-500 + BPC-157 (&#8220;Wolverine Stack&#8221;):<\/strong><\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Stof<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Opladning<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Vedligeholdelse<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Form\u00e5l<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">TB-500<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,5 mg 2\u00d7\/uge (4\u20136 uger)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2 mg 1\u00d7\/uge (4\u20138 uger)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Systemisk reparation, antiinflammatorisk<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">BPC-157<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250\u2013500 mcg 2\u00d7\/dag (4\u20136 uger)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250 mcg 1\u00d7\/dag (4\u20138 uger)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Lokal heling, angiogenese<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">Fulde BPC-157-protokoller: se vores <a href=\"https:\/\/cleanpeptides.eu\/da\/bpc-157-doseringsguide\/\">BPC-157-doseringsguide<\/a>. TB-500 + GH-sekretagoger (CJC-1295, ipamorelin): tilf\u00f8jer GH-medieret restitution og kollagenoms\u00e6tning.<\/p>\n<h2 class=\"wp-block-heading\">Sikkerhed, bivirkninger og kontraindikationer<\/h2>\n<p class=\"wp-block-paragraph\">Generelt veltolereret; T\u03b24 er et naturligt forekommende protein. Humane fors\u00f8g er begr\u00e6nsede.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Almindelige (milde, forbig\u00e5ende):<\/strong> midlertidig sl\u00f8vhed\/tr\u00e6thed (de f\u00f8rste 1\u20132 uger), let hovedpine, reaktioner ved injektionsstedet. <strong>Ualmindelige:<\/strong> varmef\u00f8lelse i hovedet, kvalme, influenzalignende symptomer.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Kontraindikationer:<\/strong> aktiv kr\u00e6ft (fremmer proliferation\/angiogenese); graviditet og amning; b\u00f8rn\/unge; aktiv infektion p\u00e5 injektionsstedet; forsigtighed hos immunsv\u00e6kkede.<\/p>\n<p class=\"wp-block-paragraph\">Ikke FDA-godkendt; kildekvalitet betyder noget (kr\u00e6v en tredjeparts-COA); WADA-forbudt.<\/p>\n<h2 class=\"wp-block-heading\">Almindelige fejl<\/h2>\n<ul class=\"wp-block-list\">\n<li>At springe opladningsfasen over (v\u00e6vsm\u00e6tning er n\u00f8dvendig).<\/li>\n<li>At forveksle mg med mcg (en standarddosis er 2\u20132,5 mg).<\/li>\n<li>At injicere lokalt i stedet for systemisk.<\/li>\n<li>At k\u00f8re opladningen for l\u00e6nge (mere end 6 uger).<\/li>\n<li>Fejl i rekonstitueringsmatematikken.<\/li>\n<li>At forvente resultater fra dag til dag (bedring ved 2\u20133 uger).<\/li>\n<li>Ikke at holde pause efter forl\u00e6nget brug.<\/li>\n<li>Forkert opbevaring efter rekonstituering.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Hovedpunkter<\/h2>\n<ul class=\"wp-block-list\">\n<li>Syntetisk fragment af thymosin beta-4; fremmer v\u00e6vsreparation via aktinopregulering.<\/li>\n<li>Standardopladning 2\u20132,5 mg 2\u00d7\/uge 4\u20136 uger, derefter vedligeholdelse 2 mg 1\u00d7\/uge.<\/li>\n<li>Systemisk \u2014 injicer hvor som helst SC.<\/li>\n<li>Bedst til bl\u00f8ddelsskader; bedste kombination TB-500 + BPC-157.<\/li>\n<li>Rekonstitu\u00e9r med bakteriostatisk vand; brug inden for 28\u201330 dage; kontraindiceret ved aktiv kr\u00e6ft.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Referencer<\/h2>\n<ol class=\"wp-block-list\">\n<li>Goldstein AL, et al. &#8220;Thymosin \u03b24: a multi-functional regenerative peptide.&#8221; Expert Opin Biol Ther. 2012;12(1):37-51.<\/li>\n<li>Malinda KM, et al. &#8220;Thymosin \u03b24 accelerates wound healing.&#8221; J Invest Dermatol. 1999;113(3):364-368.<\/li>\n<li>Bock-Marquette I, et al. &#8220;Thymosin \u03b24 activates ILK and promotes cardiac repair.&#8221; Nature. 2004;432(7016):466-472.<\/li>\n<li>Philp D, et al. &#8220;Thymosin \u03b24 promotes angiogenesis, wound healing, and hair follicle development.&#8221; Ann N Y Acad Sci. 2007;1112:95-103.<\/li>\n<li>Smart N, et al. &#8220;Thymosin \u03b24 and angiogenesis.&#8221; Angiogenesis. 2007;10(4):229-241.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Download og relaterede ressourcer<\/h2>\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/cleanpeptides.eu\/wp-content\/uploads\/2026\/07\/03-TB-500-Dosage-Guide-Clean-Peptides.pdf\" target=\"_blank\" rel=\"noopener\">\ud83d\udcc4 Download PDF-guide<\/a><\/p>\n<p class=\"wp-block-paragraph\">K\u00f8b TB-500: <a href=\"https:\/\/cleanpeptides.eu\/product\/tb-500-10-mg\/\">TB-500 10 mg<\/a> \u00b7 <a href=\"https:\/\/cleanpeptides.eu\/product\/tb-500-5-mg\/\">TB-500 5 mg<\/a><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"excerpt":{"rendered":"<p>Thymosin beta-4-fragment \u2014 oplednings-, vedligeholdelses- og cyklusprotokoller, rekonstituering, kombination med BPC-157 og sikkerhed. Kun til forskningsform\u00e5l \u2014 ikke til human [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-10212","page","type-page","status-publish","hentry"],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/comments?post=10212"}],"version-history":[{"count":0,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10212\/revisions"}],"wp:attachment":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/media?parent=10212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}